Stone Ridge Asset Management LLC Innoviva, Inc. Transaction History

Stone Ridge Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$10.28 - $14.38 $140,424 - $196,430	-13,660 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$10.05 - $14.55 $16,080 - $23,280	-1,600 Reduced 10.48%	13,660 $144,000
Q2 2019 Aug 06, 2019	SELL	$13.1 - $14.95 $148,030 - $168,935	-11,300 Reduced 42.55%	15,260 $222,000
Q1 2019 May 14, 2019	SELL	$13.69 - $20.06 $163,171 - $239,095	-11,919 Reduced 30.98%	26,560 $373,000
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $140,912 - $184,316	10,094 Added 35.56%	38,479 $671,000
Q3 2018 Nov 06, 2018	BUY	$13.63 - $15.7 $228,643 - $263,367	16,775 Added 144.49%	28,385 $433,000
Q2 2018 Aug 13, 2018	BUY	$13.44 - $17.59 $156,038 - $204,219	11,610 New	11,610 $160,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Stone Ridge Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Stone Ridge Asset Management LLC with notifications on news.